The Natural History of Hereditary Colorectal Cancer Syndromes: From Phenotype to Genotype? Where Do We Stand and What Does the Future Hold?

被引:0
|
作者
Church, James [1 ,2 ]
机构
[1] Columbia Univ, Div Colorectal Surg, Dept Surg, Med Ctr, New York, NY USA
[2] Columbia Univ, Div Colorectal Surg, Dept Surg, Med Ctr, Herbert Irving Pavil,161 Ft Washington Ave,8th Flo, New York, NY 10032 USA
关键词
hereditary colorectal cancer; molecular genetics of colorectal cancer; GERMLINE MUTATIONS; SERRATED POLYPOSIS; GENE; COLON; DNA; IDENTIFICATION; DISEASE; RECTUM;
D O I
10.1055/s-0043-1770380
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Applying the concept of a "natural history" to hereditary colorectal cancer is an interesting exercise because the way the syndromes are approached has changed so drastically. However, the exercise is instructive as it forces us to think in depth about where we are, where we have been, and, most helpfully, about where we may be going. In this article the diagnosis, along with endoscopic and surgical management of hereditary colorectal cancer are discussed in the context of their history and the changes in genomics and technology that have occurred over the last one hundred years.
引用
收藏
页码:127 / 132
页数:6
相关论文
共 50 条
  • [21] Disposable devices for RIRS: Where do we stand in 2013? What do we need in the future?
    Richard H. Shin
    Michael E. Lipkin
    Glenn M. Preminger
    World Journal of Urology, 2015, 33 : 241 - 246
  • [22] RCC New Drugs: Where Do They Fit? What Does the Future Hold?
    Choueiri, Toni K.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (12) : 28 - 31
  • [23] New and Developing Therapies in Spinal Muscular Atrophy: From Genotype to Phenotype to Treatment and Where Do We Stand?
    Chen, Tai-Heng
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (09)
  • [24] Cancer screening in the aging population: Where do we stand and what can we do?
    Cao, Wei
    Chen, Wanqing
    JOURNAL OF THE NATIONAL CANCER CENTER, 2022, 2 (03): : 127 - 129
  • [25] Artificial Intelligence in Senology - Where Do We Stand and What Are the Future Horizons?
    Mundinger, Alexander
    Mundinger, Carolin
    EUROPEAN JOURNAL OF BREAST HEALTH, 2024, 20 (02) : 73 - 80
  • [26] The renin-angiotensin system - Where do we stand, and what is the future?
    Hamet, P
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (09) : 125S - 126S
  • [27] Endoscopic Options for Gastroesophageal Reflux: Where Are We Now and What Does the Future Hold?
    Triadafilopoulos G.
    Current Gastroenterology Reports, 2016, 18 (9)
  • [28] Awareness of Colorectal Cancer Risk Factors in Palestine: Where Do We Stand?
    Elshami, Mohamedraed
    Dwikat, Mohammad F.
    Al-Slaibi, Ibrahim
    Alser, Mohammed
    Mohamad, Balqees M.
    Isleem, Wejdan S.
    Shurrab, Adela
    Yaghi, Bashar
    Qabaja, Yahya Ayyash
    Naji, Shoruq A.
    Hmdan, Fatima K.
    Ayyad, Mohammed M.
    Sweity, Raneen R.
    Jneed, Remah T.
    Assaf, Khayria A.
    Albandak, Maram E.
    Hmaid, Mohammed M.
    Awwad, Iyas I.
    Alhabil, Belal K.
    Alarda, Marah N.
    Alsattari, Amani S.
    Aboyousef, Moumen S.
    Aljbour, Omar A.
    AlSharif, Rinad
    Giacaman, Christy T.
    Alnaga, Ali Y.
    Abu Nemer, Ranin M.
    Almadhoun, Nada M.
    Skaik, Sondos M.
    Bottcher, Bettina
    Abu-El-Noor, Nasser
    JCO GLOBAL ONCOLOGY, 2022, 8
  • [29] Where Do We Stand With Aspirin for the Prevention of Colorectal Cancer? The USPSTF Recommendations
    Chan, Andrew T.
    Ladabaum, Uri
    GASTROENTEROLOGY, 2016, 150 (01) : 14 - 18
  • [30] NOD2 mutations and colorectal cancer - Where do we stand?
    Branquinho, Diogo
    Freire, Paulo
    Sofia, Carlos
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2016, 8 (04): : 284 - 293